Skip to main navigation Skip to search Skip to main content

Targeting KRAS-mutant non-small-cell lung cancer: One mutation at a time, with a focus on KRAS G12C mutations

  • Timothy F. Burns
  • , Hossein Borghaei
  • , Suresh S. Ramalingam
  • , Tony S. Mok
  • , Solange Peters
  • University of Pittsburgh
  • Emory University
  • The Chinese University of Hong Kong
  • University of Lausanne

Research output: Contribution to journalArticlepeer-review

56 Scopus citations
Original languageEnglish
Pages (from-to)4208-4218
Number of pages11
JournalJournal of Clinical Oncology
Volume38
Issue number35
DOIs
StatePublished - Dec 10 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Carcinoma, Non-Small-Cell Lung/drug therapy
  • Humans
  • Lung Neoplasms/drug therapy
  • Models, Molecular
  • Molecular Targeted Therapy
  • Mutation
  • Protein Kinase Inhibitors/pharmacology
  • Proto-Oncogene Proteins p21(ras)/antagonists & inhibitors

Cite this